Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals' antibody therapy shown effective in model for allergic asthma
Published in Genetics and Environmental Health Week, June 14th, 2006
The compound used in the research is a surrogate of eculizumab, Alexion's lead anti-complement antibody. The study shows that anti-C5 monoclonal antibodies, including eculizumab, can be successfully aerosolized for therapeutic use.
The data were presented at the annual meeting of the American Association of Immunologists in Boston by Yi Wang, PhD, Senior Research Fellow at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Health Week
More Articles from Genetics and Environmental Health Week
- Aichi Cancer Center
New findings from Aichi Cancer Center described - Akademiska Sjukhuset, Uppsala
Body mass index and age are related to habitual snoring in women - Aletheia University, Taipei
Cardiac abnormalities in workers exposed to carbon disulfide implicate importance of controls - All India Institute of Medical Sciences
Mycobacterium bovis and Mycobacterium tuberculosis detected in cerebrospinal fluid - All India Institute of Medical Sciences, New Delhi
Reports from All India Institute of Medical Sciences, New Delhi add new data to knowledge base - American Academy of Neurology
Lead exposure leads to brain cell loss and damage years later - More from this issue of Genetics and Environmental Health Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
